Colgate-Palmolive Company CL has experienced steady growth over the past year, fueled by its strong leadership in the oral care market and science-driven innovations that have bolstered its core and ...

Colgate-Palmolive Company CL is in a good spot, thanks to its robust business strategies. Strong pricing and funding-the-growth and other productivity initiatives have been bolstering the company’s ...

The U.S. Food and Drug Administration issued a warning letter, but not a recall, after microorganisms were found in water samples and finished toothpaste products. By Johnny Diaz Colgate-Palmolive, ...

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you ...

Colgate-Palmolive's valuation outlook, premium product expansion, margin improvement, and the factors influencing future growth expectations.

A 15% year-to-date loss at a time when broader benchmarks are flirting with all-time highs may be enough to cause some investors to write off Colgate-Palmolive, but there are some sparks that could ...

We came across a bullish thesis on Colgate-Palmolive Company (CL) on Kontra Investment Xchange’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on CL. Colgate-Palmolive ...

Is CL a good stock to buy? We came across a bullish thesis on Colgate-Palmolive Company on Investing Lawyer’s Substack. In this article, we will summarize the bulls’ thesis on CL. Colgate-Palmolive ...

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you ...

Colgate-Palmolive Company (NYSE:CL) reported third-quarter FY23 sales growth of 10.5% year-on-year to $4.915 billion, beating the analyst consensus estimate of $4.814 billion. Organic sales increased ...

Hi, everyone. Good afternoon. Welcome to the UBS Global Consumer Retail Conference here in New York City. My name is Peter Grom, I'm the U.S. Beverages and Household Products analyst here at UBS. And ...